Short answer
LENZ Therapeutics, Inc. (LENZ) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Earnings release covers quarter ended June 30, 2026.
LENZ Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings release covers quarter ended June 30, 2026
- Press release attached as Exhibit 99.1, containing LENZ’s financial results and operating updates
- Investor focus: quarterly performance, cash position, and outlook disclosed in Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LENZ Therapeutics, Inc. 8-K filings
Get the next LENZ 8-K as it lands
Follow LENZ for push alerts, or ask the research agent what this filing means.